A detailed history of Life Pro Asset Management transactions in Johnson & Johnson stock. As of the latest transaction made, Life Pro Asset Management holds 2,451 shares of JNJ stock, worth $379,929. This represents 0.3% of its overall portfolio holdings.

Number of Shares
2,451
Previous 3,577 31.48%
Holding current value
$379,929
Previous $522,000 23.95%
% of portfolio
0.3%
Previous 0.42%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$145.48 - $167.38 $163,810 - $188,469
-1,126 Reduced 31.48%
2,451 $397,000
Q2 2024

Jul 10, 2024

BUY
$144.38 - $157.78 $13,138 - $14,357
91 Added 2.61%
3,577 $522,000
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $31,354 - $32,873
-202 Reduced 5.48%
3,486 $551,000
Q4 2023

Feb 15, 2024

SELL
$145.6 - $158.88 $7,571 - $8,261
-52 Reduced 1.39%
3,688 $578,000
Q3 2023

Oct 05, 2023

SELL
$155.75 - $174.48 $744,329 - $833,839
-4,779 Reduced 56.1%
3,740 $582,000
Q2 2023

Jul 11, 2023

BUY
$154.35 - $166.11 $674,818 - $726,232
4,372 Added 105.43%
8,519 $1.41 Million
Q4 2022

Feb 15, 2023

BUY
$160.2 - $179.79 $8,650 - $9,708
54 Added 1.32%
4,147 $732,000
Q3 2022

Nov 03, 2022

SELL
$161.33 - $179.52 $110,511 - $122,971
-685 Reduced 14.34%
4,093 $669,000
Q2 2022

Jul 15, 2022

SELL
$168.19 - $186.01 $6,559 - $7,254
-39 Reduced 0.81%
4,778 $848,000
Q1 2022

May 06, 2022

SELL
$158.14 - $179.59 $111,488 - $126,610
-705 Reduced 12.77%
4,817 $854,000
Q4 2021

Jan 31, 2022

BUY
$155.93 - $173.01 $148,289 - $164,532
951 Added 20.81%
5,522 $945,000
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $19,541 - $21,715
121 Added 2.72%
4,571 $738,000
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $956 - $1,026
6 Added 0.14%
4,450 $733,000
Q1 2021

Apr 28, 2021

SELL
$153.07 - $170.48 $22,195 - $24,719
-145 Reduced 3.16%
4,444 $730,000
Q4 2020

Feb 08, 2021

BUY
$137.11 - $157.38 $629,197 - $722,216
4,589 New
4,589 $722,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Life Pro Asset Management Portfolio

Follow Life Pro Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Pro Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Life Pro Asset Management with notifications on news.